Benzinga
08 Dec 2025, 18:23 UTC · 45w ago
Verdict
Headline takes no side. We score ACLX +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Which stocks this story touches
More positive than 99% of ticker scores this week
Strong Phase 2 data for anito-cel showed a 96% overall response rate and positive analyst ratings.
More positive than 78% of ticker scores this week
Gilead is the partner for anito-cel, which demonstrated best-in-class efficacy and safety data.
Continue reading
5 related stories
Top 1 mover · tap to explore
More positive than 76% of relationship scores this week
[mutual] Arcellx is partnered with Kite Pharma, a Gilead Sciences company, for anito-cel.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
9h ago
+65.4%
Price agrees with the score
$115.07 vs $69.56 close before publication (Dec 5) · not market-adjusted
ACLX chart →
